Study of urinary leukotriene E4 levels in children with acute asthma

Ghada Saad Abd El-Motaleb1, Alraohaa Ahmed Ahmed Abou Amer1, Gamal Mohamed Elawa2

  • 1Department of Pediatrics, Faculty of Medicine, Benha University, Benha, Qalyubia, Egypt.

Insights

Urinary leukotriene E4 (ULTE4) and total serum immunoglobulin E (TS IgE) are elevated in children with acute asthma. Higher ULTE4 levels correlate with increased asthma severity, suggesting its use as a noninvasive marker.

Area of Science:

  • Pediatrics
  • Allergy and Immunology
  • Biochemistry

Background:

  • Asthma exacerbations in children are often linked to inflammatory processes.
  • Leukotriene E4 (LTE4) is a key mediator in allergic inflammation.
  • Assessing inflammatory markers can aid in managing pediatric asthma.

Purpose of the Study:

  • To evaluate urinary leukotriene E4 (ULTE4) levels in children experiencing acute asthma exacerbations.
  • To correlate ULTE4 levels with total serum immunoglobulin E (TS IgE) and asthma severity.

Main Methods:

  • A prospective study involving 63 children with acute asthma exacerbations and 25 healthy controls.
  • Measurement of urinary LTE4 (adjusted for creatinine) and serum IgE using enzyme-linked immunosorbent assay.
  • Clinical assessment of asthma severity and medical history collection.

Main Results:

  • Significantly higher ULTE4 levels were observed in asthmatic children compared to controls (309.7±97.1 vs. 14.5±5.7 pg/mg creatinine).
  • ULTE4 levels showed a positive correlation with TS IgE and asthma severity.
  • TS IgE levels were also significantly elevated in asthmatic children.

Conclusions:

  • Elevated ULTE4 and TS IgE levels are characteristic of acute asthma episodes in children.
  • ULTE4 serves as a valuable noninvasive biomarker for monitoring asthma exacerbations and inflammation in pediatric patients.
Abstract

Related Concept Videos

Antiasthma Drugs: Leukotriene Modifiers01:19

Antiasthma Drugs: Leukotriene Modifiers

Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
2.2K
Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
112
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.3K
Asthma III: Clinical Manifestations01:13

Asthma III: Clinical Manifestations

Asthma presents with a characteristic pattern of episodic respiratory symptoms that reflect underlying airway inflammation, bronchoconstriction, and mucus hypersecretion. Although severity varies among individuals, certain clinical manifestations are considered hallmarks of the disorder and often guide diagnosis and assessment.Respiratory SymptomsA persistent cough is one of the most common early features of asthma. It is frequently dry and tends to worsen at night or in the early morning,...
49
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.5K
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.6K